Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results

E Schiff; CL Lai; S Hadziyannis; P Nuehaus; N Terrault; M Colombo; H Tillmann; D Samuel; S Zuezem; JP Villenueve; S Arteburn; K Borroto-Esoda; C Brosgart; S Chuck; AO Shakil; J Fung; A Alberti; A Lok; A Picciotto; F Torre; C Riely; C Trepo; T Bizollon; D Bottaa-Fridlund; R Gerolami; D Douglas; D Ranjan; D Faust; J Trojan; E Gane; E Villa; M Boarino; E Sokal; P Starkel; F Bonino; B Maurizio; F Gordon; JA Pratt; F Berr; I Schiefke; G McCaughan; S Strasser; G Dusheiko; GP Pageaux; D Larrey; G Pastore; T Santantonio; G Alexander; T Woodall; H Van Vlierberghe; I Colle; H Harley; J Guggenheim; A Myx-Staccini; JM Metreau; P Mavier; J Vierling; T Tran; N Girgrah; L Nyberg; MF Yuen; M Ma; MD Balnco; M Merli; P Tanzilli; M Angelico; D Di Paolo; M Rizzetto; A Marzano; P Lampertico; M Prieto; M Berenguer; M Felder; M Sterneck; M Willems; M Charlton; T Gunneson; M Ritter; M Voight; J Swift; M Shiffman; N Tassopoulos; I Klissas; N Naourmov; P Chamouard; P Marcellin; F Durand; P Angus; C Nathan; P Toniutto; E Fumo; P Andreone; C Cursaro; R Barcena; FG Hoz; R Zachoval; M Christina; RA De Man; H Metselaar

Journal article

Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results

E Schiff, CL Lai, S Hadziyannis, P Nuehaus, N Terrault, M Colombo, H Tillmann, D Samuel, S Zuezem, JP Villenueve, S Arteburn, K Borroto-Esoda, C Brosgart, S Chuck, AO Shakil, J Fung, A Alberti, A Lok, A Picciotto, F Torre Show all

Liver Transplantation | Published : 2007

DOI: 10.1002/lt.20981

Abstract

Wait-listed (n = 226) or post-liver transplantation (n = 241) chronic hepatitis B (CHB) patients with lamivudine-resistant hepatitis B virus (HBV) were treated with adefovir dipivoxil for a median of 39 and 99 weeks, respectively. Among wait-listed patients, serum HBV DNA levels became undetectable (View full abstract